Consistent with our single-cohort analyses, cross-cohort prognostic CNAs were significantly more common than prognostic mutations, and TP53 was the only gene whose mutation status was associated with outcome in more than one cancer type (Figure 5—figure supplement 2A). The gene discussed is TP53; the disease is cancer.